Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Buffalo › NPI 1982650578
Physician

Pundt, Mark

Pundt, Mark was paid $232K by Medicaid between Dec 2020 and Jun 2021, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 83% of everything it billed.

33Billing provider infoPUNDT, MARK
BUFFALO, NY 14203
33aNPI1982650578assigned 05/25/2006
28Total paid$232K
24GClaims4,414
24DCodes billed4
24AFirst – last monthDec 2020 – Jun 2021
Compared with peers

Next to other Emergency Medicine Physician providers in New York

Rank by total paid#103 of 2,113
Median peer was paid$5K
This provider vs. median51×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202056$1K
20214,358$231K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 83% 2,179 571 $193K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 16% 2,179 571 $38K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 21 19 $872.29
87428 <1% 35 15 $523.72

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.